arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2303.09056cs.AI
收藏

为基于人工智能的疾病轨迹预测和药物开发数字孪生生成合成多维分子介体时间序列数据:考虑因素

Generating synthetic multi-dimensional molecular-mediator time series data for artificial intelligence-based disease trajectory forecasting and drug development digital twins: Considerations

University of Vermont Larner College of Medicine(佛蒙特大学拉纳医学院)

Gary An, Chase Cockrell

摘要:

合成数据的使用被认为是开发基于神经网络的人工智能(AI)系统的关键一步。虽然为其他领域的人工智能应用生成合成数据的方法在某些生物医学人工智能系统中发挥作用,主要与图像处理有关,但在为人工智能任务生成时间序列数据方面存在关键差距,需要知道系统如何工作。这在生成合成多维分子时间序列数据(SMMTSD)的能力中最为明显;这是支持生物标志物和介体特征研究的数据类型,用于预测各种疾病,并且是药物开发管道的重要组成部分。我们认为,统计和以数据为中心的机器学习(ML)生成这种类型的合成数据的手段不足是由于以下因素的组合:永久的数据稀疏性由于诅咒的非线性,中心极限定理的不适用性,以及因果层次定理的限制。或者,我们提出了一个理由,使用复杂的多尺度机制为基础的仿真模型,构建和操作,以考虑认知的不完整性和需要提供最大的扩展性与最大熵的原则一致。这些过程提供了SMMTD的生成,其最小化了与神经网络AI系统相关联的已知缺点,即过拟合和缺乏泛化能力。生成解释多维时间序列数据的已识别因素的合成数据是开发基于介体-生物标志物的AI预测系统以及通过药物开发数字孪生等系统进行治疗控制开发和优化的基本能力。

英文摘要:

The use of synthetic data is recognized as a crucial step in the development of neural network-based Artificial Intelligence (AI) systems. While the methods for generating synthetic data for AI applications in other domains have a role in certain biomedical AI systems, primarily related to image processing, there is a critical gap in the generation of time series data for AI tasks where it is necessary to know how the system works. This is most pronounced in the ability to generate synthetic multi-dimensional molecular time series data (SMMTSD); this is the type of data that underpins research into biomarkers and mediator signatures for forecasting various diseases and is an essential component of the drug development pipeline. We argue the insufficiency of statistical and data-centric machine learning (ML) means of generating this type of synthetic data is due to a combination of factors: perpetual data sparsity due to the Curse of Dimensionality, the inapplicability of the Central Limit Theorem, and the limits imposed by the Causal Hierarchy Theorem. Alternatively, we present a rationale for using complex multi-scale mechanism-based simulation models, constructed and operated on to account for epistemic incompleteness and the need to provide maximal expansiveness in concordance with the Principle of Maximal Entropy. These procedures provide for the generation of SMMTD that minimizes the known shortcomings associated with neural network AI systems, namely overfitting and lack of generalizability. The generation of synthetic data that accounts for the identified factors of multi-dimensional time series data is an essential capability for the development of mediator-biomarker based AI forecasting systems, and therapeutic control development and optimization through systems like Drug Development Digital Twins.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑